Hoberman Kenneth

Chief Operating Officer at STEMLINE THERAPEUTICS INC · on record since Apr 4, 2013
Director at Nuvectis Pharma, Inc. · on record since Jun 12, 2026
Director at MANHATTAN PHARMACEUTICALS INC · on record since Jun 15, 2026

Insider trading activity of Hoberman Kenneth

Transactions on record: 99; since Nov 27, 2013

Open-market buys: 2; $126.4K

Open-market sells: 43; $5.8M

Companies traded: 3; last filing Jun 15, 2026

Figures computed from official regulatory filings — methodology.

Companies where Hoberman Kenneth has traded

MANHATTAN PHARMACEUTICALS INC12 tx · Jun 15, 2026
Nuvectis Pharma, Inc.6 tx · $104.4K · Jun 12, 2026
STEMLINE THERAPEUTICS INC81 tx · $6M · Jun 10, 2020

Track record of Hoberman Kenneth

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hoberman Kenneth

Co-insiders of Hoberman Kenneth

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
MANHATTAN PHARMACEUTICALS INC	Jun 15, 2026	AwardD	8,325	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	Jun 12, 2026	Award	35,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jun 16, 2025	Award	14,718	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	Jun 12, 2025	Award	30,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jun 20, 2024	Award	22,250	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	Jun 13, 2024	Award	30,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Sep 29, 2023	Award	20,000	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	Jun 20, 2023	Award	18,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jul 22, 2022	Award	43,732	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	May 16, 2022	Buy	6,000	17.40 USD	$104.4K	SEC
Nuvectis Pharma, Inc.	Apr 5, 2022	AwardD	15,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jun 22, 2021	Award	20,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jun 24, 2020	Award	15,000	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Jun 10, 2020	Other	-1,374,352	—	—	SEC
STEMLINE THERAPEUTICS INC	Jun 10, 2020	OtherD	-44,058	—	—	SEC
STEMLINE THERAPEUTICS INC	Jun 10, 2020	OtherD	-25,000	—	—	SEC
STEMLINE THERAPEUTICS INC	Jun 10, 2020	Award	600,000	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Mar 13, 2020	Sell	-9,487	5.08 USD	$48.2K	SEC
STEMLINE THERAPEUTICS INC	Mar 13, 2020	Sell	-16,704	4.91 USD	$82K	SEC
STEMLINE THERAPEUTICS INC	Feb 28, 2020	Sell	-11,547	6.42 USD	$74.1K	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-97,580	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-132,176	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-18,070	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-18,070	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-75,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
MANHATTAN PHARMACEUTICALS INC	Jun 15, 2026	AwardD	8,325	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	Jun 12, 2026	Award	35,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jun 16, 2025	Award	14,718	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	Jun 12, 2025	Award	30,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jun 20, 2024	Award	22,250	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	Jun 13, 2024	Award	30,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Sep 29, 2023	Award	20,000	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	Jun 20, 2023	Award	18,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jul 22, 2022	Award	43,732	0.00 USD	$0	SEC
Nuvectis Pharma, Inc.	May 16, 2022	Buy	6,000	17.40 USD	$104.4K	SEC
Nuvectis Pharma, Inc.	Apr 5, 2022	AwardD	15,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jun 22, 2021	Award	20,000	0.00 USD	$0	SEC
MANHATTAN PHARMACEUTICALS INC	Jun 24, 2020	Award	15,000	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Jun 10, 2020	Other	-1,374,352	—	—	SEC
STEMLINE THERAPEUTICS INC	Jun 10, 2020	OtherD	-44,058	—	—	SEC
STEMLINE THERAPEUTICS INC	Jun 10, 2020	OtherD	-25,000	—	—	SEC
STEMLINE THERAPEUTICS INC	Jun 10, 2020	Award	600,000	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Mar 13, 2020	Sell	-9,487	5.08 USD	$48.2K	SEC
STEMLINE THERAPEUTICS INC	Mar 13, 2020	Sell	-16,704	4.91 USD	$82K	SEC
STEMLINE THERAPEUTICS INC	Feb 28, 2020	Sell	-11,547	6.42 USD	$74.1K	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-97,580	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-132,176	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-18,070	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-18,070	0.00 USD	$0	SEC
STEMLINE THERAPEUTICS INC	Feb 14, 2020	GiftD	-75,000	0.00 USD	$0	SEC